Table 3.4. Number of newly reported cases* of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2019

Table 3.4. Number of newly reported cases* of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2019
Table 2.4. Number of newly reported cases* of perinatal hepatitis B, by state or jurisdiction — United States, 2019
Source: CDC, National Notifiable Diseases Surveillance System.
* Reported cases that met the classification criteria for a confirmed case. For case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-c-perinatal-infection/.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.

Downloads of this table: PDF PPT

Standardized perinatal hepatitis C case notifications to CDC began during 2018, with implementation of the National Notifiable Diseases Surveillance System case definition. The capacity of health departments for conducting perinatal hepatitis C surveillance varies on the basis of different factors, including local testing and laboratory reporting practices and resources for case management and follow-up. As capacity for viral hepatitis surveillance improves, CDC anticipates that the number of perinatal hepatitis C cases identified and reported to CDC will increase with time.

During 2019, a total of 24 states reported 217 cases of perinatal hepatitis C. The states with the highest reported number of perinatal hepatitis C cases include Ohio (n = 41), Florida (n = 20), and Pennsylvania (n = 20).

Hepatitis C Figures and Tables